"Unlike MSB who dredge the data from failed trials, managed to cherry pick something they could claim as a "success" and then declared they would try to do a new trial in a special group of patients where efficacy seemed it might be better."
Was that the dredge the FDA asked for, come back to us with the group who experienced the most benefit from the CHF trial, which also happened to be at the highest risk of death? Was that the people who were ischemic diabetics (or is that the wrong term)?
Ann: Trading Halt, page-231
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
0.035(2.35%) |
Mkt cap ! $1.689B | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.58 | $1.41 | $12.85M | 8.588M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 22173 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.53 | 56171 | 11 |
View Market Depth
| Last trade - 13.15pm 07/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |